My research focuses on developing an advanced Gut-on-a-Chip microfluidic system that accurately replicates the conditions found in the intestine. This model allows for the precise study of interactions between intestinal cells, the microbiome, and the immune system under conditions similar to those in vivo.
The main goal of the project is to assess the impact of the microbiome on the development of inflammatory bowel diseases (IBD). The integration of microfluidic technologies with cell biology and immunology enables controlled and reproducible studies of the mechanisms underlying these diseases.
The approach being developed aims to improve our understanding of the pathogenesis of IBD and support the development of new, more personalized therapeutic strategies.